Table 4
Anti-TNFα discontinuation
Both treatments(n = 25)
Etanercept(n = 10)
Infliximab(n = 15)
Discontinuation
17
7
10
Lack of efficacy
11
5
6
Side effect
4
1
3
Other
2
1
1